Envision Pharma Group Acquires 90TEN

InductiveHealth Acquires Envision Technology Partners

January 29, 2025

Software

InductiveHealth has acquired Envision Technology Partners to combine disease and syndromic surveillance capabilities with Envision’s immunization information system (WebIZ), creating a unified public health platform. The deal aims to improve interoperability across public health systems, accelerate implementations, and enhance analytics for federal, state and local public health agencies.

ClinicalMind Acquires 11TEN Innovation Partners

April 23, 2024

Healthcare Services

ClinicalMind, a healthcare marketing and communications firm based in New York, has acquired 11TEN Innovation Partners, an Atlanta-based healthcare strategy and innovation consulting firm. The acquisition combines ClinicalMind's medical communications, training, and technology capabilities with 11TEN's commercial strategy and innovation ecosystem to offer integrated end-to-end services for life sciences clients.

Envision Pharma Group Acquires OKRA.ai

February 8, 2023

AI & Machine Learning

Envision Pharma Group, a portfolio company of GHO Capital, has acquired OKRA.ai, an award-winning AI technology provider for the life sciences industry. The add-on expands Envision's technology-enabled capabilities in AI, real-world evidence and data analytics to better support pharmaceutical and biotech clients across the product lifecycle.

Envision Pharma Group Acquires doDOC

March 22, 2021

Software

Envision Pharma Group, a portfolio company of GHO Capital Partners, has acquired doDOC Corp., a Boston-founded SaaS platform for collaborative document review and authoring tailored to the life sciences. doDOC will operate as a business unit under its existing brand and be integrated into Envision's iEnvision medical affairs platform to expand document collaboration capabilities and improve workflow efficiency.

Envision Pharma Group Acquires Two Labs

November 12, 2020

Healthcare Services

Envision Pharma Group has acquired Two Labs, a Powell, Ohio-based provider of pharmaceutical commercialization, launch planning, market access and market intelligence services. The deal, which follows increased investment in Envision from GHO Capital, strengthens Envision's US presence and expands its launch-excellence capabilities; Excellere Partners will exit its investment in Two Labs.

GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian

November 5, 2020

Healthcare Services

GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.